Overview
Daniel Gudbjartsson practices in Reykjavik, Iceland. Mr. Gudbjartsson is rated as an Experienced expert by MediFind in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). His top areas of expertise are Sick Sinus Syndrome, Coronary Heart Disease, Familial Hypercholesterolemia, and Hartnup Disease.
His clinical research consists of co-authoring 276 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Attention Deficit Hyperactivity Disorder (ADHD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Coronary Heart DiseaseMr. Gudbjartsson isAdvanced. Learn about Coronary Heart Disease.
- Sick Sinus SyndromeMr. Gudbjartsson isAdvanced. Learn about Sick Sinus Syndrome.
- Experienced
- 15q11.2 MicrodeletionMr. Gudbjartsson isExperienced. Learn about 15q11.2 Microdeletion.
- Abdominal Aortic Aneurysm (AAA)Mr. Gudbjartsson isExperienced. Learn about Abdominal Aortic Aneurysm (AAA).
- Adenine Phosphoribosyltransferase DeficiencyMr. Gudbjartsson isExperienced. Learn about Adenine Phosphoribosyltransferase Deficiency.
- Alport SyndromeMr. Gudbjartsson isExperienced. Learn about Alport Syndrome.
- Angelman SyndromeMr. Gudbjartsson isExperienced. Learn about Angelman Syndrome.
- AppendicitisMr. Gudbjartsson isExperienced. Learn about Appendicitis.